Skip to main content
Top
Published in: Diabetologia 7/2004

01-07-2004 | Article

Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy

Authors: C. Müller, F. J. Neumann, M. Ferenc, A. P. Perruchoud, H. J. Büttner

Published in: Diabetologia | Issue 7/2004

Login to get access

Abstract

Aims/hypothesis

We sought to evaluate the impact of diabetes mellitus on long-term outcome in patients with unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy.

Methods

We carried out a prospective cohort study in 270 diabetic and 1163 non-diabetic patients with unstable angina and non-ST-segment elevation myocardial infarction. All patients underwent coronary angiography and, if appropriate, subsequent revascularisation within 24 hours of admission. The primary endpoint was all-cause mortality during follow-up for up to 60 months.

Results

Diabetic patients had less favourable baseline characteristics including more advanced coronary artery disease and more severe unstable angina and non-ST-segment elevation myocardial infarction. Percutaneous coronary intervention was performed in 53% of diabetic patients and 56% of non-diabetic patients. Coronary artery bypass grafting was done in 21% of diabetic patients and 12% of non-diabetic patients. In-hospital mortality (4.1% vs 1.3%; hazard ratio 3.47; 95% CI: 1.57 to 7.64; p=0.002) and long-term mortality (9.7% vs 4.9%; hazard ratio 2.11; 95% CI: 1.33 to 3.36; p=0.002) were significantly higher in diabetic patients. After adjustment for differences in baseline characteristics, diabetes mellitus was no longer an independent predictor of long-term mortality (hazard ratio 1.43; 95% CI: 0.74 to 2.78; p=0.292).

Conclusions/interpretation

Diabetic patients treated with a very early invasive strategy for unstable angina and non-ST-segment elevation myocardial infarction have a higher in-hospital and long-term mortality that is largely explained by their less favourable baseline characteristics including more advanced coronary artery disease and more severe unstable angina and non-ST-segment elevation myocardial infarction.
Literature
1.
go back to reference Abbott RD, Donahue RP, Kannel WB, Wilson PW (1988) The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 260:3456–3460CrossRefPubMed Abbott RD, Donahue RP, Kannel WB, Wilson PW (1988) The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 260:3456–3460CrossRefPubMed
2.
go back to reference Butler WJ, Osrander LD Jr, Carman WJ, Lamphiear DE (1985) Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose intolerance, and other risk factors. Am J Epidemiol 121:541–547CrossRefPubMed Butler WJ, Osrander LD Jr, Carman WJ, Lamphiear DE (1985) Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose intolerance, and other risk factors. Am J Epidemiol 121:541–547CrossRefPubMed
3.
go back to reference Mueller C, Mc Hodgson JB, Brutsche M et al. (2002) Impact of intracoronary ultrasound guidance on long-term outcome of percutaneous coronary interventions in diabetics—insights from the randomised SIPS trial. Swiss Med Wkly 132:279–284PubMed Mueller C, Mc Hodgson JB, Brutsche M et al. (2002) Impact of intracoronary ultrasound guidance on long-term outcome of percutaneous coronary interventions in diabetics—insights from the randomised SIPS trial. Swiss Med Wkly 132:279–284PubMed
4.
go back to reference Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–34CrossRefPubMed Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–34CrossRefPubMed
5.
go back to reference Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297CrossRefPubMed Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297CrossRefPubMed
6.
go back to reference King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed
7.
go back to reference Fava S, Azzorpadi J, Agius-Muscat H (1997) Outcome of unstable angina in patients with diabetes mellitus. Diabet Med 14:209–213CrossRefPubMed Fava S, Azzorpadi J, Agius-Muscat H (1997) Outcome of unstable angina in patients with diabetes mellitus. Diabet Med 14:209–213CrossRefPubMed
8.
go back to reference Wilcox I, Freedman SB, Allman KC et al. (1991) Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 18:667–683CrossRef Wilcox I, Freedman SB, Allman KC et al. (1991) Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 18:667–683CrossRef
9.
go back to reference Calvin JE, Klein LW, Van den Berg BJ et al. (1995) Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 273:136–141CrossRefPubMed Calvin JE, Klein LW, Van den Berg BJ et al. (1995) Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 273:136–141CrossRefPubMed
10.
go back to reference Gowda MS, Vacek JL, Hallas D (1998) One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol 89:1067–1071CrossRef Gowda MS, Vacek JL, Hallas D (1998) One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol 89:1067–1071CrossRef
11.
go back to reference Malmberg K, Yusuf S, Gerstein HC et al. (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction. Results of the OASIS (Organization to assess strategies for ischemic syndromes) registry. Circulation 102:1014–1019CrossRefPubMed Malmberg K, Yusuf S, Gerstein HC et al. (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction. Results of the OASIS (Organization to assess strategies for ischemic syndromes) registry. Circulation 102:1014–1019CrossRefPubMed
12.
go back to reference Cannon CP, Weintraub WS, Demopoulos LA et al. (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Iib/IIIa inhibitor tirofiban. N Engl J Med 344:1879–1887CrossRefPubMed Cannon CP, Weintraub WS, Demopoulos LA et al. (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Iib/IIIa inhibitor tirofiban. N Engl J Med 344:1879–1887CrossRefPubMed
13.
go back to reference Norhammar A, Malmberg K, Diderholm E et al. (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43:585–591CrossRefPubMed Norhammar A, Malmberg K, Diderholm E et al. (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43:585–591CrossRefPubMed
14.
go back to reference Neumann FJ, Kastrati A, Pogatsa-Murray G et al. (2003) Evaluation of prolonged antithrombotic pretreatment (“cooling-off strategy”) before intervention in patients with unstable coronary syndromes. A randomized controlled trial. JAMA 290:1593–1599CrossRefPubMed Neumann FJ, Kastrati A, Pogatsa-Murray G et al. (2003) Evaluation of prolonged antithrombotic pretreatment (“cooling-off strategy”) before intervention in patients with unstable coronary syndromes. A randomized controlled trial. JAMA 290:1593–1599CrossRefPubMed
15.
go back to reference Braunwald E, Antman EM, Beasley JW et al. (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Available from http://www.acc.org/clinical/guidelines/unstable/unstable.pdf, accessed 1 February 2004 Braunwald E, Antman EM, Beasley JW et al. (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Available from http://​www.​acc.​org/​clinical/​guidelines/​unstable/​unstable.​pdf, accessed 1 February 2004
16.
go back to reference The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (2002) Management of acute coronary syndromes in patients presenting without ST-segment elevation. Eur Heart J 23:1809–1840CrossRef The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (2002) Management of acute coronary syndromes in patients presenting without ST-segment elevation. Eur Heart J 23:1809–1840CrossRef
18.
go back to reference Van Belle E, Périé M, Braune D et al. (2002) Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40:410–417CrossRef Van Belle E, Périé M, Braune D et al. (2002) Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40:410–417CrossRef
19.
go back to reference Detre KM, Guo P, Holubkov R et al. (1999) Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99:633–40CrossRefPubMed Detre KM, Guo P, Holubkov R et al. (1999) Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99:633–40CrossRefPubMed
20.
go back to reference Conlan MG, Folsom AR, Finch A et al. (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380–385PubMed Conlan MG, Folsom AR, Finch A et al. (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380–385PubMed
21.
go back to reference Tracy RP, Bovill EG, Fried LP et al. (1992) The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years: results from the Cardiovascular Health Study. Ann Epidemiol 2:509–519CrossRefPubMed Tracy RP, Bovill EG, Fried LP et al. (1992) The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years: results from the Cardiovascular Health Study. Ann Epidemiol 2:509–519CrossRefPubMed
22.
go back to reference Stegnar M, Pentek M (1993) Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin. Thromb Res 69:81–92CrossRefPubMed Stegnar M, Pentek M (1993) Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin. Thromb Res 69:81–92CrossRefPubMed
23.
go back to reference Johansson S, Bergstrand R, Schlossman D, Selin K, Vedin A, Wilhelmsson C (1984) Sex differences in cardioangiographic findings after myocardial infarction. Eur Heart J 5:374–381CrossRefPubMed Johansson S, Bergstrand R, Schlossman D, Selin K, Vedin A, Wilhelmsson C (1984) Sex differences in cardioangiographic findings after myocardial infarction. Eur Heart J 5:374–381CrossRefPubMed
24.
go back to reference Levenson J, Pessana F, Gariepy J, Armentano R, Simon A (2001) Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol 38:1668–1674CrossRefPubMed Levenson J, Pessana F, Gariepy J, Armentano R, Simon A (2001) Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol 38:1668–1674CrossRefPubMed
25.
go back to reference Mueller C, Neumann FJ, Roskamm H et al. (2002) Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominately with percutaneous coronary intervention: a prospective study in 1450 consecutive patients. J Am Coll Cardiol 40:245–250CrossRefPubMed Mueller C, Neumann FJ, Roskamm H et al. (2002) Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominately with percutaneous coronary intervention: a prospective study in 1450 consecutive patients. J Am Coll Cardiol 40:245–250CrossRefPubMed
Metadata
Title
Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy
Authors
C. Müller
F. J. Neumann
M. Ferenc
A. P. Perruchoud
H. J. Büttner
Publication date
01-07-2004
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1450-3

Other articles of this Issue 7/2004

Diabetologia 7/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.